According to a recent analysis, the Glaucoma Therapeutics Market is expected to reach over US$10.2 million by 2032, reflecting a steady increase from US$6.9 million in 2022. This translates to a Compound Annual Growth Rate (CAGR) of 3.7%, driven by a concerning trend – the rising number of people diagnosed with glaucoma worldwide. Research published in the National Institutes of Health (NCBI) journal highlights glaucoma as a major threat to vision globally. With the growing need for effective treatments, the glaucoma therapeutics market is expected to see steady expansion in the coming
By treatment type, the medication eye drops segment will hold the maximum market share for the global glaucoma therapeutics market due to its high preference by physicians for medication during the early stages of treatment.
Laser surgery is preferred to traditional surgery by both surgeons and patients owing to the low risk of failure. By glaucoma type, closed glaucoma will dominate the maximum market share attributed to its greater prevalence than open glaucoma.
Request for a sample
https://www.futuremarketinsights.com/reports/sample/rep-gb-6456
Glaucoma Therapeutics Market: Drivers and Restraints:
The change in the lifestyle of people has resulted in a rise in the prevalence of glaucoma globally. The increasing prevalence of glaucoma is the primary factor driving the growth of the glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. The rising geriatric population throughout the globe is also responsible for the robust growth of the glaucoma therapeutics market over the forecast period. Increasing preference of physicians towards laser surgery for the treatment of glaucoma will propel the growth of the glaucoma therapeutics market over the forecast period.
Less awareness among the people about the glaucoma treatment will deter the growth of the glaucoma therapeutics market to some extent. Moreover, the lack of availability of skilled professionals for laser surgery in developing economies will also hamper the growth of the glaucoma therapeutics market. Glaucoma is an eye disease that damages the patient’s eye nerve optics. The formation of extra fluid up in the front part of the eye resultsthe damage to eye nerve optics. Glaucoma is of two types, primary open-angle glaucoma, and angle-closure glaucoma which is also referred to as closed-angle glaucoma or narrow-angle glaucoma. Open-angle glaucoma is the most common type of glaucoma. Primary glaucoma gradually happens when the eye does not drain the fluids. This results in the building of pressure on eye nerve optics. Open glaucoma causes no change in the eye vision and it is painless too.
Closed-angle glaucoma happens very close to the drainage angle which results in the blocking of the drainage angle of eyesight. This is a very acute type of glaucoma. This type of glaucoma may affect the vision of the patient and it may cause severe pain to the eye and headache. Glaucoma is generally treated with eye drops, pills, traditional surgery, laser surgery, and sometime the combination of these methods. The aim of glaucoma treatment is to avoid the vision loss of a patient wherever if the vision of a particular patient is already lost then it is irreversible by glaucoma treatment. Regular consumption of medication as prescribed by the physician is very necessary for the proper treatment of glaucoma. The drugs for glaucoma have very few chances of effects which has increased its adoption in the global market.
Glaucoma Therapeutics Market: Key Players
Some of the players across the value chain of the Glaucoma Therapeutics market are Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer and Santen, and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and industries.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-6456
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, UK, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Glaucoma Therapeutics Market: Segmentation
The global Glaucoma Therapeutics market is classified based on treatment type, glaucoma type, and geographic region.
Based on the treatment type
- Eye Drops
- Medication
- Laser Surgery
- Traditional Surgery
Based on glaucoma type
- Open-angle glaucoma
- Closed-angle glaucoma
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
